Beta Bionics, Inc. Increase (Decrease) in Other Noncurrent Assets
Beta Bionics, Inc. (BBNX) reported Increase (Decrease) in Other Noncurrent Assets of -$39.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-07-29
- Beta Bionics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$40.00K.
- Beta Bionics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $1.00K.
- Beta Bionics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$3.00K.
- Beta Bionics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $39.00K, a 11.43% increase year-over-year.
- Beta Bionics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $30.00K, a 3.45% increase from fiscal 2024.
- Beta Bionics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $29.00K, a 3.57% increase from fiscal 2023.
- Beta Bionics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $28.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$39.00K 10-Q · filed 2026-07-29 | -$42.00K derived: sum of 3 quarters · filed 2026-07-29 | -$3.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $1.00K 10-Q · filed 2026-04-21 | -$2.00K derived: sum of 2 quarters · filed 2026-04-21 | $37.00K derived: sum of 3 quarters · filed 2026-04-21 | $35.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $36.00K derived: sum of 2 quarters · filed 2026-02-24 | $34.00K derived: sum of 3 quarters · filed 2026-07-29 | $30.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $37.00K derived: sum of 2 quarters · filed 2026-07-29 | $33.00K 10-Q · filed 2025-10-28 | $32.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$6.00K 10-Q · filed 2026-07-29 | -$7.00K derived: sum of 3 quarters · filed 2026-07-29 | $28.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$4.00K 10-Q · filed 2026-04-21 | -$5.00K derived: sum of 2 quarters · filed 2026-04-21 | $30.00K derived: sum of 3 quarters · filed 2026-04-21 | $26.00K derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $34.00K derived: sum of 2 quarters · filed 2026-02-24 | $30.00K derived: sum of 3 quarters · filed 2026-02-24 | $29.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $31.00K derived: sum of 2 quarters · filed 2025-10-28 | $30.00K 10-Q · filed 2025-10-28 | |
| 2024-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$5.00K 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | -$1.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $28.00K 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |